Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I could be wrong

If we the shareholders, put forth one or more nominees that will in essence create a situation where there are more nominees than board seats and should the current board of directors allow this to happen, then I agree there may be no reason for us to push for by- law changes at this time.

For if, the new nominees did in fact receive more votes than any of the other candidates, thereby replacing them, the hope would be that they would see to it that the bylaws are changed according to the will of the shareholders..

Of course under this scenario, the votes could be for those we think should be replaced. I will have to accept what is.


Apr 29, 2010 02:44PM
Share
New Message
Please login to post a reply